Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-068502

Options or other derivatives

  • Director acquired 11,918 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PARMAR KUSH · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +11,918 11,918 D
Loading xslF345X03/tm2217670-3_4seq1.xml…